FDA Clearance Tracker · K202927
EYE-SYNC
Last checked: Nov 20, 2026Latest source record: Oct 2, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Oct 2, 2021
Substantially Equivalent
Time to decision
368 days
Received Sep 29, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K202927
- Device name
- EYE-SYNC
- Applicant
- Syncthink, Inc.
- Applicant location
- Palo Alto, CA
- Received
- Sep 29, 2020
- Decided
- Oct 2, 2021
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 882.1455
- Specialty
- Neurology & Neurosurgery
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code QEA. The earliest in FDA's data is DEN170091, decided Dec 28, 2018.
- It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).
Source documents
- FDA database record for K202927
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Syncthink, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- EYE-SYNC510(k)
K152915 · Decided Jan 29, 2016 · 119 days after receipt
Device type: Nystagmograph (GWN) · Neurology & Neurosurgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.